Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.
about
Neuroimmune pharmacological approachesCannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritisRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationMapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe.Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s).AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.Endocannabinoid signaling at the periphery: 50 years after THC.Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes.The Role of the Endocannabinoid System in the Brain-Gut Axis.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review.The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.Cannabinoid Receptor-2 Ameliorates Inflammation in Murine Model of Crohn's Disease.Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice.A reliable and validated LC-MS/MS method for the simultaneous quantification of 4 cannabinoids in 40 consumer products.
P2860
Q26782927-8BFAF3A8-3438-4390-8DA0-51E0F3DCCC4AQ26783956-8B45F9FD-FA24-40E9-9C94-66A57D0BA5AAQ30357558-94AC1C1C-A18A-4BC3-8AAD-69AB8881755FQ30842363-37AB4375-E75D-4D5D-B364-F5800568950FQ34500324-D479FC67-6439-4854-8D37-6DEF7972B020Q35484505-4722862C-65CE-4306-B39F-0A48F8472281Q35572176-6E5027B5-ACB4-4BBE-B68F-DBF4F843BFA0Q36157657-13E38F24-E9ED-4075-937E-B1B8F9E286EAQ36720905-2416AE8D-5066-49DB-9A4A-467727C632F7Q37032490-587F1F84-D204-4549-AF3B-EC6F26645D4DQ38815860-37314365-BEF5-49E6-B57F-4726198AD38AQ38822341-D3A8F2BB-7236-445C-9575-37DCE63CDE74Q38918638-C7293F13-A157-45D5-8D80-95D6328DCDE1Q39025067-6096F1B6-2ECC-4744-A7DB-D628F9541F3FQ41821312-F81ABADB-4148-4793-9207-583399146A2FQ49579501-EED44353-80DB-4E9F-A116-4594DF5CA736Q52762339-90FDE00F-1869-464F-B273-F825A49C0639Q55019713-11139DDA-0C76-483A-B5FE-D70E9D058014
P2860
Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@ast
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@en
type
label
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@ast
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@en
prefLabel
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@ast
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@en
P2093
P2860
P50
P921
P1433
P1476
Cannabinoids alleviate experim ...... tral and peripheral receptors.
@en
P2093
Donna-Marie McCafferty
Ganesh A Thakur
Martin Storr
Misha Bawa
Ritesh Tichkule
P2860
P304
P356
10.1371/JOURNAL.PONE.0109115
P407
P577
2014-10-02T00:00:00Z